| Compound Name | HTRF | AlphaLISA | Cytotoxicity |
|---|---|---|---|
| Albuterol hemisulfate | 1.27 ± 0.79 (83) | 2.76 ± 1.16 (82) | Inactive |
| (-)-α-Methylnorepinephrine | 0.17 ± 0.02 (96) | 0.12± 0.04 (118) | Inactive |
| Bay 11-7082 | 1.22 ± 0.11 (103) | 1.22 ± 0.33 (121) | 7.30 ± 0.59 (107) |
| Bay 11-7085 | 0.87 ± 0.16 (100) | 0.74 ± 0.17 (107) | 10.4 ± 2.53 (103) |
| BTO-1 | 6.15 ± 0.57 (74) | 2.96 ± 1.62 (101) | 17.4 ± 2.82 (54) |
| CCG-2046 | 2.59 ± 0.17 (93) | 1.15 ± 0.38 (168) | 12.9 ± 1.1 (80) |
| Dobutamine hydrochloride | 0.44 ± 0.04 (92) | 0.51 ± 0.06 (104) | Inactive |
| Ellipticine | 4.06 ± 1.28 (108) | 1.57 ± 0.41 (121) | 14.5 ± 1.18 (110) |
| (-)-Epinephrine bitartrate | 0.05 ± 0.01 (96) | 0.07 ± 0 (71) | Inactive |
| (±)-Epinephrine hydrochloride | 0.14 ± 0.01 (97) | 0.15 ± 0.03 (121) | Inactive |
| Fenoterol hydrobromide | 0.12 ± 0.012 (96) | 0.12 ± 0.057 (110) | Inactive |
| Formoterol | 0.004 ± 0.001 (88) | 0.006 ±.0039 (90) | Inactive |
| Histamine dihydrochloride | 1.11 ± 0.401 (77) | 1.89 ± 0.26 (61) | Inactive |
| IRAK-1/4 Inhibitor I | 2.68 ± 0.37 (88) | 1.12 ± 0.06 (103) | Inactive |
| (±)-Isoproterenol hydrochloride | 0.016 ± 0.001 (93) | 0.016 ± 0.003 (100) | Inactive |
| Isotharine mesylate | 1.83 ± 1.69 (103) | 2.07 ± 0.93 (98) | Inactive |
| L(-)-Norepinephrine bitartrate | 0.12 ± 0.01 (88) | 0.10 ± 0.03 (170) | Inactive |
| Metaproterenol hemisulfate | 0.52 ± 0.10 (91) | 0.60 ± 0.10 (104) | Inactive |
| N-p-Tosyl-L-phenylalanine chloromethyl ketone | 2.64 ± 0.63 (94) | 1.08 ± 0.26 (210) | 29.1 ± 2.36 (125) |
| Parthenolide | 2.51 ± 0.28 (103) | 1.30 ± 0.50 (120) | 8.89 ± 2.84 (79) |
| PD 169316 | 0.11 ± 0.04 (77) | 0.14 ± 0.10 (91) | 30.7 ± 0 (62) |
| Ritodrine hydrochloride | 2.52 ± 0.27 (71) | 3.498 ± 0.73 (71) | Inactive |
| S(+)-Isoproterenol(+)-bitartrate | 0.056 ± 0.003 (96) | 0.071 ± 0.004 (101) | Inactive |
| Salbutamol | 1.78 ± 1.42 (67) | 3.34 ± 2.34 (77) | Inactive |
| Terbutaline hemisulfate | 2.88 ± 0.71 (103) | 2.18 ± 1.02 (112) | Inactive |